228 related articles for article (PubMed ID: 3015015)
1. Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.
Hussy P; Maass G; Tümmler B; Grosse F; Schomburg U
Antimicrob Agents Chemother; 1986 Jun; 29(6):1073-8. PubMed ID: 3015015
[TBL] [Abstract][Full Text] [Related]
2. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.
Tabary X; Moreau N; Dureuil C; Le Goffic F
Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840
[TBL] [Abstract][Full Text] [Related]
3. [Comparative in vitro study of the activity of 5 quinolones against Acinetobacter calcoaceticus].
Joly-Guillou ML; Bergogne-Berezin E
Pathol Biol (Paris); 1985 May; 33(5):416-20. PubMed ID: 3162142
[TBL] [Abstract][Full Text] [Related]
4. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
5. Novobiocin and nalidixic acid target proteins in yeast.
Nakayama K; Sugino A
Biochem Biophys Res Commun; 1980 Sep; 96(1):306-12. PubMed ID: 6254510
[No Abstract] [Full Text] [Related]
6. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
Smith JT
Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
[TBL] [Abstract][Full Text] [Related]
7. The mode of action of 4-quinolones and possible mechanisms of resistance.
Smith JT
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():21-9. PubMed ID: 3542946
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.
Moreau NJ; Robaux H; Baron L; Tabary X
Antimicrob Agents Chemother; 1990 Oct; 34(10):1955-60. PubMed ID: 1963290
[TBL] [Abstract][Full Text] [Related]
9. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
10. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
Renaudin H; Quentin C; de Barbeyrac B; Bebear C
Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
[TBL] [Abstract][Full Text] [Related]
11. Dependence of mammalian DNA synthesis on DNA supercoiling. III. Characterization of the inhibition of replicative and repair-type DNA synthesis by novobiocin and nalidixic acid.
Mattern MR; Scudiero DA
Biochim Biophys Acta; 1981 Apr; 653(2):248-58. PubMed ID: 6261824
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of seven quinolones against 100 clinical isolates of Clostridium difficile.
Delmee M; Avesani V
Antimicrob Agents Chemother; 1986 Feb; 29(2):374-5. PubMed ID: 2940968
[TBL] [Abstract][Full Text] [Related]
13. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro studies with 4-quinolone antimicrobials.
Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus.
Hoshino K; Sato K; Une T; Osada Y
Antimicrob Agents Chemother; 1989 Oct; 33(10):1816-8. PubMed ID: 2556080
[TBL] [Abstract][Full Text] [Related]
16. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
Zeiler HJ
Drugs Exp Clin Res; 1985; 11(5):335-8. PubMed ID: 2941261
[TBL] [Abstract][Full Text] [Related]
17. 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro.
Forsgren A; Schlossman SF; Tedder TF
Antimicrob Agents Chemother; 1987 May; 31(5):768-73. PubMed ID: 3606076
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Digranes A; Dibb WL; Benonisen E
Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA gyrase by optically active ofloxacin.
Imamura M; Shibamura S; Hayakawa I; Osada Y
Antimicrob Agents Chemother; 1987 Feb; 31(2):325-7. PubMed ID: 3032098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
